EpiFaith CV for Central Venous Catheterization

September 20, 2023 updated by: National Taiwan University Hospital

The Overall Surgical Time Comparison Between EpiFaith® CV and Conventional Syringe in Central Venous Catheterization

EpiFaith CV provides automatic aspiration and detection of arterial pressure as an alternative to manometry in central venous catheterization. The aim of the study is to evaluate if it may reduce operation time compared with conventional syringe.

Study Overview

Detailed Description

Central venous catheterization (CVC) is crucial in modern perioperative and intensive care. Keeping constant and stable negative pressure while advancing the needle had been issue for beginners. Recently, EpiFaith CV provides a new solution for CVC, which facilitates syringe control and precision during assessing vessels. It provides steady aspiration and detection of arterial pressure as an alternative to manometry without the need to disconnect nor more connections. The aim of the study is to evaluate if it may reduce operation time compared with conventional syringe.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Man-Ling Wang, MD, PhD
  • Phone Number: 262158 +886-2312-3456
  • Email: mlwang@ntu.edu.tw

Study Locations

      • Taipei, Taiwan, 100
        • National Taiwan University Hospital
        • Contact:
          • Man-Ling Wang, MD, PhD
          • Phone Number: 262158 +886-2-2312-3456
          • Email: mlwang@ntu.edu.tw

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria (for participants):

  • 18 years old and above
  • Surgical patients who need to have a central venous catheter placed
  • Informed and agree to participate in the study

Inclusion Criteria (for conducting physicians):

  • Physicians with >100 central venous catheter placement experience, including attending physicians and senior residents

Exclusion Criteria (for participants):

  • Patient refusal
  • Puncture site skin lesions
  • Uncorrected coagulation disorder
  • Hemodynamic instability
  • Not informed and consented to participate in research

Exclusion Criteria (for conducting physicians):

  • Not informed and consented to participate in research

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: EpiFaith CV
The conducting physicians in this group will use EpiFaith CV to localize the central vein and assess if there is arterial puncture
The conducting physician will localize the central vein using EpiFaith CV and assess if there is arterial puncture.
Active Comparator: Conventional
The conducting physicians in this group will use Raulerson syringe to localize the central vein and assess if there is arterial puncture
The conducting physician will localize the central vein using Raulerson syringe and assess if there is arterial puncture.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The overall surgical time
Time Frame: 1 hour
The time from needle insertion, aspiration of blood, assessment of vein or artery, insertion of guidewire, until removal of the needle
1 hour

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Amount of blood drawn
Time Frame: 1 hour
The total amount of blood drawn during the procedure
1 hour
Number of attempts to place guidewire
Time Frame: 1 hour
Number of attempts to place guidewire during the procedure
1 hour
Arterial puncture rate
Time Frame: 1 hour
The rate of arterial puncture during the procedure
1 hour
Arterial puncture identification rate
Time Frame: 1 hour
The rate of identification of arterial puncture
1 hour
Success rate
Time Frame: 1 hour
The rate for successful central venous catheterization within 3 attempts
1 hour
Likert scale for satisfaction
Time Frame: 1 hour
Likert scale for satisfaction of using either device for central venous catheterization and qualitative measurement for user experiences
1 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Man-Ling Wang, MD, PhD, Department of Anesthesiology, National Taiwan University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 1, 2023

Primary Completion (Estimated)

June 1, 2024

Study Completion (Estimated)

December 1, 2024

Study Registration Dates

First Submitted

September 12, 2023

First Submitted That Met QC Criteria

September 12, 2023

First Posted (Actual)

September 21, 2023

Study Record Updates

Last Update Posted (Actual)

September 22, 2023

Last Update Submitted That Met QC Criteria

September 20, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

There is a plan to make IPD and related data dictionaries available.

IPD Sharing Time Frame

Starting 6 months after publication

IPD Sharing Access Criteria

The PI will review requests

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Perioperative Care

Clinical Trials on EpiFaith CV

3
Subscribe